Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19Read More about Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19
By Dr. David Saperstein Antibodies (also known as immunoglobulins) play an important role in health and illness. Many of you regularly receive intravenous immunoglobulin (IVIG) to treat your autoimmune disease. Flooding a person’s system with antibodies from normal, healthy individuals can reverse problems caused by abnormally overactive immune systems. However, providing antibodies that fight a specific infection can…Read More about What is Convalescent Plasma?
As we have postponed spring chapter meetings, fundraising walks and activities, and in the theme of “working together in new and innovative ways,” we have developed a virtual “Ask the Expert” educational series featuring medical experts from the Foundation’s Global Medical Advisory Board. Our educational series will be pre-recorded, and hosted by members of the…Read More about Join us for Virtual Ask the Experts
Partnership brings together world-leading plasma companies to focus on developing and delivering a hyperimmune immunoglobulin in the global fight against COVID-19.Read More about Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy
Patient groups praise U.S. guidelines that designate plasma centers, manufacturing sites as essential. See full articleRead More about Work Continues for CSL Behring During the Pandemic